Recent Update on Nanoemulgel as Topical Drug Delivery System

Journal of Pharmaceutical Sciences

Volumn 106, Issue 7, 2017, Pages 1736-1751

  Choudhury, Hira ^a   Gorain, Bapi ^b   Pandey, Manisha ^a   Chatterjee, Lipika Alok ^a   Sengupta, Pinaki ^c   Das, Arindam ^b   Molugulu, Nagashekhara ^a   Kesharwani, Prashant ^d  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b LINCOLN UNIVERSITY COLLEGE   (Malaysia)

^c INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^d CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

nanoemulgel; nanoemulsion; pharmacokinetic improvement; transdermal drug delivery

Indexed keywords

COSURFACTANT; GELLING AGENT; OIL; SURFACTANT; TOPICAL AGENT; WATER; DRUG; DRUG VEHICLE; EMULSIFYING AGENT;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; ENERGY; NANOEMULSION; PHARMACODYNAMICS; PHARMACOKINETICS; REVIEW; ANIMAL; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; GEL; HUMAN; METABOLISM; PROCEDURES; SKIN; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; EMULSIONS; GELS; HUMANS; OILS; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL VEHICLES; SKIN; SKIN ABSORPTION;

EID: 85019135257     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1016/j.xphs.2017.03.042     Document Type: Review

References (128)

1. Michael, P.L., Pharmacy: An Introduction to the Profession, 2nd ed. 2009, American Pharmacists Association, Washington, DC.
2. Weissig, V., Lizano, C., Torchilin, V.P., Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes. Drug Deliv 7 (2000), 1–5.
3. Beig, A., Miller, J., Lindley, D., Carr, R., Head-to-head comparison of different solubility-enabling formulations of etoposide and their consequent solubility–permeability interplay. J Pharm Sci 104 (2015), 2941–2947.
4. Gade Abhishek, V., Salunkhe, K.S., Chaudhari, S.R., Gadge, P.B., Dighe, G.S., Review on: Self micro-emulsifying drug delivery system. Am J Pharm Res 5 (2015), 50–66.
5. Pham-The, H., Garrigues, T., Bermejo, M., Provisional classification and in silico study of biopharmaceutical system based on Caco-2 cell permeability and dose number. Mol Pharm 10 (2013), 2445–2461.
6. Kesharwani, P., Banerjee, S., Padhye, S., Sarkar, F.H., Iyer, A.K., Parenterally administrable nano-micelles of 3, 4-difluorobenzylidene curcumin for treating pancreatic cancers. Colloids Surf B Biointerfaces 132 (2015), 138–145.
7. Jain, A., Jain, K., Kesharwani, P., Jain, N.K., Low density lipoproteins mediated nanoplatforms for cancer targeting. J Nanoparticle Res, 15, 2013, 1888.
8. Kesharwani, P., Xie, L., Banerjee, S., et al. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Colloids Surf B Biointerfaces 136 (2015), 413–423.
9. Gorain, B., Choudhury, H., Biswas, E., Barik, A., Jaisankar, P., Pal, T.K., A novel approach for nanoemulsion components screening and nanoemulsion assay of olmesartan medoxomil through a developed and validated HPLC method. RSC Adv 3 (2013), 10887–10893.
10. Gorain, B., Choudhury, H., Kundu, A., et al. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces 115 (2014), 286–294.
11. Kaushal, A., Gupta, P., Bansal, A., Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst 21 (2004), 133–193.
12. Kawakami, K., Pikal, M., Calorimetric investigation of the structural relaxation of amorphous materials: evaluating validity of the methodologies. J Pharm Sci 94 (2005), 948–965.
13. Ghanghoria, R., Kesharwani, P., Agashe, H.B., Jain, N.K., Transdermal delivery of cyclodextrin-solubilized curcumin. Drug Deliv Transl Res 3 (2013), 272–285.
14. Kothule, K.U., Kesharwani, P., Gidwani, S.K., Gide, P., Development and characterization of chitosan nanoparticles and improvement of oral bioavailability of poorly water soluble acyclovir. Res J Pharm Technol 3 (2010), 1241–1245 Available at: http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=3&issue=4&article=062 Accessed June 13, 2015.
15. Gorain, B., Tekade, M., Kesharwani, P., Iyer, A.K., Kalia, K., Tekade, R.K., The use of nanoscaffolds and dendrimers in tissue engineering. Drug Discov Today 22:4 (2017), 652–664.
16. Pouton, C., Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and “self-microemulsifying” drug delivery systems. Eur J Pharm Sci 11:Suppl. 2 (2000), S93–S98.
17. Bali, V., Ali, M., Ali, J., Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int J Pharm 403 (2011), 45–56.
18. Shafiq-un-Nabi, S., Shakeel, F., Talegaonkar, S., et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech, 8, 2007 Article 28.
19. Choudhury, H., Gorain, B., Chatterjee, B., Mandal, U.K., Sengupta, P., Tekade, R.K., Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route. Curr Pharm Des, 2016 [Epub ahead of print].
20. Parveen, R., Baboota, S., Ali, J., Ahuja, A., Vasudev, S.S., Ahmad, S., Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int J Pharm 413 (2011), 245–253.
21. Mansuri, S., Kesharwani, P., Tekade, R.K., Jain, N.K., Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole. Eur J Pharm Biopharm 102 (2016), 202–213.
22. Shukla, A., Mishra, V., Kesharwani, P., Bilosomes in the context of oral immunization: development, challenges and opportunities. Drug Discov Today 21 (2016), 888–899.
23. Shafaat, K., Kumar, B., Das, S.K., Ul Hasan, R., Prajapati, S.K., Novel nanoemulsion as vehicles for transdermal delivery of clozapine: in vitro and in vivo studies. Int J Pharm Pharm Sci 5 (2013), 126–134.
24. Zhou, J., Zhou, M., Yang, F.F., et al. Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. Mol Pharm 12 (2015), 1084–1095.
25. Kotta, S., Khan, A.W., Ansari, S.H., Sharma, R.K., Ali, J., Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation. Int J Pharm 462 (2014), 129–134.
26. Iqbal, M., Md, S., Sahni, J., Baboota, S., Nanostructured lipid carriers system: recent advances in drug delivery. J Drug 20 (2012), 813–830.
27. Kaur, J., Kaur, J., Jaiswal, S., Gupta, G., Recent advances in topical drug delivery system. Indo Am J Pharm Res 6 (2016), 6353–6369.
28. Shakeel, F., Baboota, S., Ahuja, A., et al. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnology, 6, 2008, 8.
29. Huang, X., Peng, X., Wang, Y., et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4 (2010), 5887–5896.
30. Delouise, L.A., Applications of nanotechnology in dermatology. J Invest Dermatol 132 (2012), 964–975.
31. Gao, F., Zhang, Z., Bu, H., et al. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism. J Control Release 149 (2011), 168–174.
32. Khurana, S., Bedi, P.M.S., Jain, N.K., Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem Phys Lipids 175–176 (2013), 65–72.
33. Pund, S., Pawar, S., Gangurde, S., Divate, D., Transcutaneous delivery of leflunomide nanoemulgel: mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. Int J Pharm 487 (2015), 148–156.
34. Sonneville-Aubrun, O., Simonnet, J., L'alloret, F., Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci 108–109 (2004), 145–149.
35. Tadros, T., Izquierdo, P., Esquena, J., Solans, C., Formation and stability of nano-emulsions. Adv Colloid Interface Sci 108 (2004), 303–318.
36. Solans, C., Izquierdo, P., Nolla, J., Azemar, N., Garcia-Celma, M.J., Nano-emulsions. Curr Opin Colloid Interf Sci 10 (2005), 102–110.
37. Formariz, T., Sarmento, V., Silva-Junior, A., Doxorubicin biocompatible O/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine. Colloids Surf B Biointerfaces 51 (2006), 54–61.
38. Gorain, B., Choudhury, H., Tekade, R.K., Karan, S., Jaisankar, P., Pal, T.K., Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion. Regul Toxicol Pharmacol 82 (2016), 20–31.
39. Aparna, C., Srinivas, P., Patnaik, K.S.K.R., Enhanced transdermal permeability of telmisartan by a novel nanoemulsion gel. Int J Pharm Pharm Sci 7 (2015), 335–342.
40. Harwansh, R.K., Mukherjee, P.K., Bahadur, S., Biswas, R., Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci 141 (2015), 202–211.
41. Hussain, A., Samad, A., Singh, S.K., et al. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv 23 (2016), 642–657.
42. Mirza, M.A., Ahmad, S., Mallick, M.N., Manzoor, N., Talegaonkar, S., Iqbal, Z., Development of a novel synergistic thermosensitive gel for vaginal candidiasis: an in vitro, in vivo evaluation. Colloids Surf B Biointerfaces 103 (2013), 275–282.
43. Srivastava, M., Kohli, K., Ali, M., Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis. Drug Deliv 7544 (2014), 1–13.
44. Tayel, S.A., El-Nabarawi, M.A., Tadros, M.I., Abd-Elsalam, W.H., Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 443 (2013), 293–305.
45. Rahmani-Neishaboor, E., Jallili, R., Hartwell, R., Leung, V., Carr, N., Ghahary, A., Topical application of a film-forming emulgel dressing that controls the release of stratifin and acetylsalicylic acid and improves/prevents hypertrophic scarring. Wound Repair Regen 21:1 (2013), 55–65.
46. Sultana, S., Parveen, P., Sri Rekha, M., Deepthi, K., Sowjanya, C.A., Seetha, D., Emulgel—a novel surrogate approach for transdermal drug delivery system. Indo Am J Pharm Res Indo Am J Pharm Res 4 (2014), 5250–5265.
47. Bhavesh, S., Shah, C.N., Nanoemulgel: a comprehensive review on the recent advances in topical drug delivery. Pharma Sci Monit 7:2 (2016), 346–355.
48. Chellapa, P., Mohamed, A.T., Keleb, E.I., et al. Nanoemulsion and nanoemulgel as a topical formulation. IOSR J Pharm 5 (2015), 2250–3013.
49. Ajazuddin, Alexander, A., Khichariya, A., Gupta, S., Patel, R.J., Giri, T.K., et al. Recent expansions in an emergent novel drug delivery technology: emulgel. J Control Release 171 (2013), 122–132.
50. Warisnoicharoen, W., Lansley, A.B., Lawrence, M.J., Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm 198 (2000), 7–27.
51. Sapra, B., Thatai, P., Bhandari, S., Sood, J., Jindal, M., Tiwary, A., A critical appraisal of microemulsions for drug delivery: part I. Ther Deliv 4 (2013), 1547–1564.
52. Vandamme, T., Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 21 (2002), 15–34.
53. Williams, A.C., Barry, B.W., Penetration enhancers. Adv Drug Deliv Rev 64 (2012), 128–137.
54. Arora, R., Aggarwal, G., Harikumar, S.L., et al. Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen. Adv Pharm 2014 (2014), 1–12.
55. Dhawan, B., Aggarwal, G., Harikumar, S., Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int J Pharm Investig 4 (2014), 65–76.
56. Kaushik, D., Batheja, P., Kilfoyle, B., Rai, V., Michniak-Kohn, B., Percutaneous permeation modifiers: enhancement versus retardation. Expert Opin Drug Deliv 5 (2008), 517–529.
57. Kanikkannan, N., Kandimalla, K., Lamba, S.S., Singh, M., Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 7 (2000), 593–608.
58. Hamed, R., Basil, M., Albaraghthi, T., Sunoqrot, S., Nanoemulsion-based gel formulation of diclofenac diethylamine: design, optimisation, rheological behavior and in vitro diffusion studies. Pharm Dev Technol 7450 (2015), 1–10.
59. Jeengar, M.K., Rompicharla, S.V.K., Shrivastava, S., et al. Emu oil based nano-emulgel for topical delivery of curcumin. Int J Pharm 506 (2016), 222–236.
60. Akram, M., Naqvi, S.B.S., Khan, A., Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation. Pak J Pharm Sci 26 (2013), 323–332.
61. Zanardo, V., Giarrizzo, D., Jeengar, M.K., et al. Re. “Review on emu products for use as complementary and alternative medicine.”. Nutrition, 31, 2015, 415.
62. Jeengar, M.K., Shrivastava, S., Mouli Veeravalli, S.C., Naidu, V.G.M., Sistla, R., Amelioration of FCA induced arthritis on topical application of curcumin in combination with emu oil. Nutrition 32 (2015), 955–964.
63. Mondello, F., De Bernardis, F., Girolamo, A., et al. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis, 6, 2006, 158.
64. Reichling, J., Landvatter, U., Wagner, H., Kostka, K.H., Schaefer, U.F., In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations. Eur J Pharm Biopharm 64 (2006), 222–228.
65. Southwell, I.A., Freeman, S., Rubel, D., Skin irritancy of tea tree oil. J Essent Oil Res 9 (1997), 47–52.
66. Bhushan, M., Beck, M., Allergic contact dermatitis from tea tree oil in a wart paint. Contact Derm 36:2 (1997), 117–118.
67. Valdivia, F., Dachs, A., Perdiguer, N., Nanoemulsion of the Oil Water Type, Useful as an Ophthalmic Vehicle and Process for the Preparation Thereof. 1997 US Pat. 5,698,219.
68. Pathak, M., Chhabra, G., Pathak, K., Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation. Drug Dev Ind Pharm 39 (2013), 780–790.
69. Srivastava, M., Neupane, Y.R., Kumar, P., Kohli, K., Nanoemulgel (NEG) of Ketoprofen with eugenol as oil phase for the treatment of ligature-induced experimental periodontitis in Wistar rats. Drug Deliv, 2016, 2228–2234.
70. Eid, A.M., El-Enshasy, H.A., Aziz, R., Elmarzugi, N.A., Preparation, characterization and anti-inflammatory activity of Swietenia macrophylla nanoemulgel. J Nanomed Nanotechnol, 5, 2014, 10.4172/2157-7439.1000190 1000190/1–1000190/10, 10.
71. Azeem, A., Rizwan, M., Ahmad, F.J., et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10 (2009), 69–76.
72. Choudhury, H., Gorain, B., Karmakar, S., et al. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. Int J Pharm 460 (2014), 131–143.
73. Dahan, A., Hoffman, A., Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release 129 (2008), 1–10.
74. Hippalgaonkar, K., Majumdar, S., Kansara, V., Injectable lipid emulsions-advancements, opportunities and challenges. AAPS PharmSciTech 11 (2010), 1526–1540.
75. Dasgupta, S., Ghosh, S.K., Ray, S., Kaurav, S.S., Mazumder, B., In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application. Curr Drug Deliv 11 (2014), 132–138.
76. Mahtab, A., Anwar, M., Mallick, N., Naz, Z., Jain, G., Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech 17 (2016), 1477–1490.
77. Malcolmson, C., Satra, C., Kantaria, S., Sidhu, A., Jayne Lawrence, M., Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. J Pharm Sci 87 (1998), 109–116.
78. Tayel, S.A., El-Nabarawi, M.A., Tadros, M.I., Abd-Elsalam, W.H., Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits. AAPS PharmSciTech 14 (2013), 782–793.
79. Silva, H.D., Cerqueira, M.A., Vicente, A.A., Influence of surfactant and processing conditions in the stability of oil-in-water nanoemulsions. J Food Eng 167 (2015), 89–98.
80. Mason, T.G., Wilking, J.N., Meleson, K., et al. Nanoemulsions: formation, structure, and physical properties. J Phys Condens Matter 18 (2006), R635–R666.
81. Sinko, P.J., Martin's Physical Pharmacy and Pharmaceutical Sciences Physical Chemical and Biopharmaceutical Principles in the Pharmaceutical Sciences. 2011, Lippincott Williams & Wilkins, Philadelphia, PA.
82. Lawrence, M.J., Rees, G.D., Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45 (2000), 89–121.
83. Shen, L., Guo, A., Zhu, X., Tween surfactants: adsorption, self-organization, and protein resistance. Surf Sci 605 (2011), 494–499.
84. Craig, D.Q.M., Barker, S.A., Banning, D., Booth, S.W., An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 114 (1995), 103–110.
85. Beringer, P., Remington: The Science and Practice of Pharmacy. 2006, Pharmaceutical Press.
86. Noor El-Din, M.R., El-Hamouly, S.H., Mohamed, H.M., Mishrif, M.R., Ragab, A.M., Water-in-diesel fuel nanoemulsions: preparation, stability and physical properties. Egypt J Pet 22 (2013), 517–530.
87. Porras, M., Solans, C., González, C., Gutiérrez, J.M., Properties of water-in-oil (W/O) nano-emulsions prepared by a low-energy emulsification method. Colloids Surf A Physicochem Eng Asp 324 (2008), 181–188.
88. Wang, L., Dong, J., Chen, J., Eastoe, J., Li, X., Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 330 (2009), 443–448.
89. Ali, M.S., Alam, M.S., Alam, N., Siddiqui, M.R., Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. Iran J Pharm Res 13 (2014), 1125–1140.
90. Kommuru, T.R., Gurley, B., Khan, M.A., Reddy, I.K., Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 212 (2001), 233–246.
91. Bali, V., Ali, M., Ali, J., Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces 76 (2010), 410–420.
92. Abdelaziz, A.E., Elmowafy, M., Salama, A., et al. Development and transdermal efficacy assessment of indomethacin nanoemulsion formulation., 4, 2014, 611–621.
93. Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Aqil, M., Shafiq, S., Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8 (2007), 191–199.
94. Musa, S.H., Basri, M., Masoumi, H.R.F., et al. Formulation optimization of palm kernel oil esters nanoemulsion-loaded with chloramphenicol suitable for meningitis treatment. Colloids Surf B Biointerfaces 112 (2013), 113–119.
95. Hu, J., Chen, D., Jiang, R., Tan, Q., Zhu, B., Zhang, J., Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine-phospholipid nanocomplex. Int J Nanomedicine 9 (2014), 4411–4420.
96. Bai, L., McClements, D.J., Formation and stabilization of nanoemulsions using biosurfactants: Rhamnolipids. J Colloid Interface Sci 479 (2016), 71–79.
97. Qian, C., McClements, D.J., Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocoll 25 (2011), 1000–1008.
98. Rosa, M.T.M.G., Silva, E.K., Santos, D.T., Petenate, A.J., Meireles, M.A.A., Obtaining annatto seed oil miniemulsions by ultrasonication using aqueous extract from Brazilian ginseng roots as a biosurfactant. J Food Eng 168 (2016), 68–78.
99. Cerón-Camacho, R., Martínez-Palou, R., Chávez-Gómez, B., et al. Synergistic effect of alkyl-O-glucoside and -cellobioside biosurfactants as effective emulsifiers of crude oil in water. A proposal for the transport of heavy crude oil by pipeline. Fuel 110 (2013), 310–317.
100. El Maghraby, G.M., Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants. Int J Pharm 355 (2008), 285–292.
101. Wang, Z., Mu, H.J., Zhang, X.M., et al. Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies. Int J Nanomed 10 (2015), 633–644.
102. Liu, W., Tian, R., Hu, W., et al. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein. Fitoterapia 83 (2012), 1532–1539.
103. Mura, S., Manconi, M., Valenti, D., Sinico, C., Vila, A.O., Fadda, A.M., Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target 19 (2011), 189–196.
104. Hua, L., Weisan, P., Jiayu, L., Ying, Z., Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev Ind Pharm 30 (2004), 657–666.
105. Attwood, D., Microemulsions. Kreuer, J., (eds.) Colloidal Drug Delivery Systems, 1994, Marcel Dekker, New York, 31–71.
106. Ngawhirunpat, T., Worachun, N., Opanasopit, P., Rojanarata, T., Panomsuk, S., Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen. Pharm Dev Technol 18 (2013), 798–803.
107. Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F.J., Khar, R.K., Ali, M., Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66 (2007), 227–243.
108. Syed, H.K., Peh, K.K., Identification of phases of various oil, surfactant/co-surfactants and water system by ternary phase diagram. Acta Pol Pharm 71 (2014), 301–309.
109. Anton, N., Vandamme, T.F., The universality of low-energy nano-emulsification. Int J Pharm 377 (2009), 142–147.
110. Flanagan, J., Kortegaard, K., Neil Pinder, D., Rades, T., Singh, H., Solubilisation of soybean oil in microemulsions using various surfactants. Food Hydrocoll, 2006, 253–260.
111. Gupta, P.K., Pandit, J.K., Kumar, A., Swaroop, P., Gupta, S., Pharmaceutical nanotechnology novel nanoemulsion—high energy emulsification preparation, evaluation and application. Pharm Res 3 (2010), 117–138.
112. Souto EB, ed. Lipid Nanocarriers in Cancer Diagnosis and Therapy. UK: ISmithers; 2011.
113. Wang, Q., Zhang, B., Self-assembled nanostructures. Nanotechnol. Res. Methods Foods Bioprod, 2012, Wiley-Blackwell, Oxford, UK, 19–40.
114. Puglia, C., Rizza, L., Drechsler, M., Bonina, F., Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: characterization and in vitro and in vivo evaluation. Drug Deliv 17 (2010), 123–129.
115. Solè, I., Pey, C.M., Maestro, A., et al. Nano-emulsions prepared by the phase inversion composition method: preparation variables and scale up. J Colloid Interface Sci 344 (2010), 417–423.
116. Lovelyn, C., Attama, A.A., Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol 2 (2011), 626–639.
117. Shah, B.M., Misra, M., Shishoo, C.J., Padh, H., Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization. Drug Deliv 7544 (2014), 1–13.
118. Hosny, K.M., Banjar, Z.M., The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin Drug Deliv 10 (2013), 1033–1041.
119. Khurana, S., Jain, N.K., Bedi, P.M.S., Development and characterization of a novel controlled release transdermal delivery system based on nanostructured lipid carriers gel for meloxicam. Life Sci 93 (2013), 763–772.
120. Hussain, A., Haque, M., Singh, S., Ahmed, F., Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II. Drug Deliv 23 (2015), 1242–1253.
121. Elosaily, G.H., Formulation and in-vitro evaluation of nystatin nanoemulsion-based gel for topical delivery. J Am Sci 8 (2012), 541–548.
122. Choudhury, H., Gorain, B., Karmakar, S., Pal, T.K., Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel. J Chromatogr Sci 52 (2014), 68–74.
123. Elosaily, G., Salem, H., Hassan, A., Formulation, in-vitro and in-vivo evaluation of nystatin topical gel. J Am Sci 10 (2014), 75–85.
124. Sampathi, S., Mankala, S., Wankar, J., Nanoemulsion based hydrogel of itraconazole for transdermal drug delivery. J Sci Ind Res 74 (2015), 88–92.
125. Tang, M.L., Chen, L.H., Zhou, D.S., Zhu, W.F., Guan, Y.M., Li, J.S., Optimized preparation of capsaicin-loaded nanoparticles gel by Box-Behnken design. Adv Mater Res 1061–1062 (2014), 359–368.
126. Andrews, S., Jeong, E., Prausnitz, M., Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res 30 (2013), 1099–1109.
127. Jain, S., Valvi, P.U., Swarnakar, N.K., Thanki, K., Gelatin coated hybrid lipid nanoparticles for oral delivery of Amphotericin B. Mol Pharm 9 (2012), 2542–2553.
128. Yang, C., Shen, Y., Wang, J., Ouahab, A., Zhang, T., Tu, J., Cationic polymer-based micro-emulgel with self-preserving ability for transdermal delivery of diclofenac sodium. Drug Deliv 7544 (2014), 1–9.